Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2013 Feb;57(2):1082–1085. doi: 10.1128/AAC.02182-12

Correlation of Cell Membrane Lipid Profiles with Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus

Nagendra N Mishra a,, Arnold S Bayer a,b
PMCID: PMC3553710  PMID: 23254419

Abstract

We compared the cell membrane (CM) lipid composition among nine well-characterized daptomycin-susceptible (Daps)/Dap-resistant (Dapr) methicillin-resistant Staphylococcus aureus (MRSA) strain pairs. Compared to the 9 Daps parental strains, Dapr strains (with or without mprF-yycFG mutations) exhibited significantly reduced phosphatidylglycerol (PG) content (P < 0.01), significantly increased total synthesis of lysyl-PG (LPG) (P < 0.01), and reduced carotenoid content (P < 0.05 for 5/9 strains). There were no significant changes in LPG flipping, cardiolipin content, or fatty acid composition among strain pairs.

TEXT

Daptomycin (Dap) is a lipopeptide antibiotic, first FDA approved in 2003, which demonstrates excellent antibacterial potency and in vivo activity against susceptible Gram-positive pathogens (17). Although both the bacterial cell membrane (CM) and cell wall (CW) are felt to participate in its bactericidal pathway, Dap principally targets the CM in a strictly calcium-dependent manner, rapidly perturbing its integrity and dissipating its electrochemical gradient, leading to cell death (8). Staphylococcus aureus utilizes adaptations in both CM phospholipid (PL) content and CW composition to modulate its relative positive surface charge as a protective mechanism, presumably against the binding and insertion of positively charged (cationic) antimicrobial peptides (CAPs), such as Dap, and host defense peptides (HDPs) (814). In addition, S. aureus can alter its carotenoid profiles to calibrate its CM order (fluidity versus rigidity) to best resist the microbicidal action of CAPs (12, 15). In these regards, S. aureus strains have been shown to accumulate single nucleotide polymorphisms (SNPs) in two particular gene loci during evolution of Dapr, mprF and yycFG (8, 12, 16). The mprF locus in S. aureus is involved in the lysinylation of CM phosphatidylglycerol (PG) to generate the positively charged species, lysyl-PG (LPG), and also promotes LPG translocation from the inner to outer CM leaflet (8, 10, 1719). In addition, mutations in yycFG (involved in the CM stress response and fatty acid biosynthesis) is a well-known accompaniment of the Dapr phenotype in S. aureus (8, 16). The aim of this study was to analyze the fatty acid (FA) and PL content of a well-characterized recent set of Daps/Dapr strain pairs.

(This work was presented in part at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 9 to 12 September 2012, abstract number C1-1744 [20].)

Nine previously published Daps/Dapr methicillin-resistant S. aureus (MRSA) clinical bloodstream strain pairs were used in this study (21). (Although the official terminology is “daptomycin nonsusceptible,” the term “daptomycin resistant” is employed in this study for a more facile presentation.) The strain pairs were initially selected on the basis of whether or not the Dapr isolate possessed an mprF SNP (with and without a concomitant yyc operon mutation) (21). Each Daps and Dapr strain pair was identical on the basis of pulsed-field gel electrophoresis (PFGE) (21). In addition, the following detailed comparative genotyping assays strongly suggested genetic identity among strain pairs: agr typing (22), spa typing, clonal complex determinations (23), and staphylococcal cassette chromosome mec element (SCCmec) typing (24). As reported before (21), among these Dapr isolates, the Dap MICs ranged from 4- to 16-fold higher than those of their respective parental Daps isolates (Table 1). In 4/10 Dapr isolates, the VISA phenotype was observed (vancomycin MICs of 4 μg/ml) (21) (Table 1).

Table 1.

Description of study strainsa

Strain MIC
USA group mprF SNP yycG SNP
Daptomycin (μg/ml) Vancomycin (μg/ml)
CB1483 0.25 1 USA100
CB185 4 2 L826Fb None
CB5079 0.5 1 USA300
CB5080 2 2 L826Fb None
CB5083 0.25 1 USA100
CB5082 4 2 L341Sc None
CB5088 0.5 1 USA300
CB5089 2–4 2 S295Lc None
CB1631 0.5 2 USA100
CB1634 4 4 L826Fb Frameshift
CB1663 0.5 1 ND
CB1664 4 4 L826Fb R86H
CB5057 0.5 1 USA300
CB5059 4 4 I420Nb T474I
CB5062 0.5 1 ND
CB5063 8 2 None None
CB5015 1 4 ND
CB5016 4 4 None None
a

Data in this table have been previously published (21). ND, not determined; none, no mutation detected.

b

Mutation in putative mprF C-terminal synthase domain.

c

Mutation in putative mprF central bifunctional domain.

Seven of the 9 Dapr strains exhibited SNPs within the mprF gene locus, with or without concomitant SNPs within yycFG, while in two of the 9 Dapr strains, there were no mutations in either gene locus (Table 1) (21).

Detailed methods for PL and FA extractions, fluorescamine labeling of outer CM LPG to define LPG translocation, FA profiling, and carotenoid quantifications have been described in detail before (8, 10, 12, 15, 2529). For PL compositional analysis, major CM PLs of S. aureus PG, LPG, and CL were separated by two-dimensional (2-D) thin-layer chromatography (TLC) using Silica 60 F254 HPTLC plates (Merck). A minimum of seven TLC plates were used from two different lipid extracts on different days for the PL analysis. Data were expressed as the mean (±SD) percentages of the three major PLs (LPG + PG + CL = 100%). Distinct FAs, i.e., total iso-branched-chain FAs (BCFA), anteiso-BCFAs, saturated FAs (SFA), and unsaturated FAs (UFA), were identified by a gas-liquid chromatography-based microbial identification system (Sherlock 4.5; courtesy of Microbial ID Inc., Newark, DE). FA data represent the means (±SD) from a minimum of two independent determinations from different FA extracts on different days. Data were expressed as the percentage of the major FAs (BCFA + SCFA + UFA = 100%). FAs present in less than 1% of the total were not included in the data analysis. For carotenoid assays, stationary-phase cultures (overnight) of S. aureus cells were subjected to methanol extraction. The absorbance profile of the extracts was measured at an optical density of 450 nm (OD450) (15). Carotenoid analyses are reported as the means (±SD) from a minimum of three independent experiments for all strains on different days.

The two-tailed Student t test was used for statistical analyses of quantitative data. P values of ≤0.05 were considered significant.

Several interesting findings were noted in this study. The Dapr MRSA strains demonstrated a significant enhancement in overall synthesis of LPG (P < 0.01), with a concomitantly reduced production of PG (P < 0.01) (Table 2). There were no statistically significant differences in CL production, and importantly, the amount of LPG which was translocated to the outer CM did not differ among strain pairs (Table 2). Of note, this same PL phenotype occurred in the presence or absence of mutations in mprF, suggesting that genetic networks outside mprF in Dapr strains may well impact the expression and/or functionality of the latter locus. In previous studies, mprF SNPs were associated either with excess production or increased flipping of LPG to the outer layer of CM, depending on their location within either the synthase or translocase domains of this locus, respectively (10, 25, 30). In the current study, the major “gain-in-function” phenotype observed was in overall LPG synthesis but not in translocation function. Thus, it would be predicted that there would be no major differences in net surface positive charge in comparing the Dapr strains with their respective Daps parental isolate. In this regard, in a recent publication using these same 9 strain pairs (21), there was no consistent pattern of surface charge differences in comparing the respective paired Daps and Dapr isolates.

Table 2.

PL content and asymmetry of LPG of 9 study strain pairs

Strain Cell membrane PL composition (% of total PL [mean ± SD])
I-LPG O-LPG Total LPG PG CL
CB1483 13.39 ± 3.5 1.91 ± 1.6 15.30 ± 3.7 77.21 ± 4.2 7.49 ± 1.8
CB185 32.10 ± 6.6a 3.85 ± 2.3 35.96 ± 6.5b 52.31 ± 4.9b 11.73 ± 7.9
CB5079 13.63 ± 3.9 1.80 ± 0.4 15.43 ± 3.9 72.12 ± 8.0 12.44 ± 6.5
CB5080 24.78 ± 4.4a 1.39 ± 0.4 26.18 ± 4.1b 64.08 ± 7.3b 9.75 ± 4.2
CB5083 10.15 ± 4.8 1.92 ± 0.7 12.07 ± 5.0 83.3 ± 6.1 4.63 ± 2.4
CB5082 19.24 ± 5.1a 2.37 ± 0.9 21.61 ± 5.9b 73.58 ± 7.2b 4.82 ± 2.6
CB5088 13.61 ± 1.6 1.75 ± 1.3 15.36 ± 2.5 77.66 ± 4.1 6.97 ± 3.7
CB5089 22.62 ± 6.0a 2.29 ± 1.4 24.91 ± 7.2b 65.93 ± 4.8b 9.16 ± 5.4
CB1631 10.25 ± 3.2 1.83 ± 0.6 12.08 ± 3.2 80.41 ± 4.3 7.51 ± 2.3
CB1634 18.68 ± 3.1a 1.93 ± 1.0 20.61 ± 3.6b 71.75 ± 4.8b 7.63 ± 2.4
CB1663 10.24 ± 2.7 1.72 ± 0.4 11.96 ± 3.0 83.20 ± 4.6 4.84 ± 2.5
CB1664 14.69 ± 1.2a 1.36 ± 0.5 16.05 ± 1.0b 81.33 ± 1.7 2.62 ± 1.8
CB5057 14.32 ± 1.6 1.59 ± 0.8 15.91 ± 1.9 79.25 ± 2.9 4.85 ± 2.0
CB5059 24.77 ± 3.9a 2.44 ± 1.5 27.22 ± 4.9b 69.92 ± 4.5b 2.87 ± 1.8
CB5062 11.49 ± 2.0 1.21 ± 0.70 12.71 ± 2.1 79.90 ± 1.6 7.40 ± 2.6
CB5063 29.23 ± 6.5a 2.33 ± 1.43 31.55 ± 7.8b 59.01 ± 6.3b 9.44 ± 2.4
CB5015 12.73 ± 1.15 1.32 ± 0.7 14.06 ± 1.0 83.31 ± 1.4 2.63 ± 1.0
CB5016 17.61 ± 3.12a 1.66 ± 0.38 19.27 ± 3.2b 77.20 ± 3.1b 3.53 ± 1.7
a

P value <0.005 versus parent strain.

b

P value <0.01 versus parent strain.

Next, liposome-based data from our laboratories have also suggested that LPG plays an additional key role beyond surface charge regulation in Dap-CM interactions (31). Thus, increases in LPG CM content (as in the current study) concomitantly reduce the proportionality of CM PG (31). It appears that the latter negatively charged PG (as well as negatively charged CL) are important participants in the initial “docking” of CAPs within target CMs. In support of this notion, Dapr strains of enterococci and Bacillus subtilis also exhibit reductions in CM PG (27, 32); in B. subtilis, derived as Dapr by serial in vitro passage in Dap, such PG content reductions are associated with an acquired mutation in pgs (the PG synthase gene locus) (32). Further, PG appears to have an independent and pivotal function in the capacity of Dap to oligomerize within target CMs (32). Thus, there are at least two mechanisms by which increases in LPG synthesis, with reciprocal decreases in PG production, may impact Dapr in a “noncharge”-based manner.

Further, our prior investigations with the same strain pairs confirmed that the Dapr isolates had more fluid CMs than their respective Daps parental strains (21). It is known that extremes of CM order (highly fluid or highly rigid CMs) can alter susceptibility to a variety of CAPs, presumably by modifying the capacity of such molecules to bind to and/or oligomerize within target CMs (33). We therefore performed a detailed FA compositional analysis (a major contributor to CM order) (8, 12, 15, 34), especially the proportionality of total iso-BCFAs, anteiso-BCFAs, SFAs, and UFAs. The Dapr strains did not exhibit any consistently or significantly altered FA content pattern compared to that of their respective Daps parental strains (data not shown).

In addition, since we have noted before that carotenoid content of the S. aureus CM affects not only its fluidity properties but also susceptibility profiles to CAPs (15), the comparative carotenoid content among strain pairs was determined. Most of the Dapr isolates (excluding CB185) exhibited less CM carotenoid content than their respective Daps parental strains (Table 3). In 5/9 strain pairs, this difference reached statistical significance (Table 3). As carotenoids can influence CM order by rigidifying their architecture, our observation of lowered carotenoid content among Dapr strains fits with their previously observed increases in CM fluidity profiles (27). A recent investigation from our laboratory involving the evolution of Dapr during in vitro passage (12) also confirmed a parallelism between CM order and carotenoid content. Thus, in the latter study, progressive evolution of Dapr during such serial in vitro passages correlated with both enhanced CM rigidity and increased carotenoid content.

Table 3.

Carotenoid profiles of study strain pairs

Strain OD450 of carotenoids P value
CB1483 0.616 ± 0.1
CB185 0.705 ± 0.07 0.19
CB5079 1.102 ± 0.08
CB5080 0.616 ± 0.10 0.003
CB5083 0.994 ± 0.10
CB5082 0.531 ± 0.11 0.006
CB5088 0.922 ± 0.15
CB5089 0.604 ± 0.01 0.06
CB1631 0.638 ± 0.03
CB1634 0.405 ± 0.06 0.02
CB1663 1.12 ± 0.06
CB1664 0.798 ± 0.10 0.01
CB5057 0.564 ± 0.01
CB5059 0.336 ± 0.05 0.01
CB5062 0.143 ± 0.04
CB5063 0.122 ± 0.02 0.5
CB5015 0.606 ± 0.07
CB5016 0.489 ± 0.04 0.07

In summary, the major CM lipid perturbation demonstrated in the current study among Dapr isolates was a hyperproduction of the positively charged PL species, LPG. This was accompanied by a concomitant reduction in CM PG content. Of interest, this unique phenotype occurred in Dapr strains both with and without mprF mutations, suggesting that gene loci and/or networks outside mprF can have a major influence on ultimate LPG biosynthesis.

ACKNOWLEDGMENTS

This research was supported by grants from the National Institutes of Health, RO1 AI-39108-14 (to A.S.B.), and from Cubist Pharmaceuticals, Lexington, MA (to A.S.B.).

We thank Aileen Rubio (Cubist Pharmaceuticals, Lexington, MA) for providing the strains for this investigation, as well as many helpful discussions and critical review of our manuscript.

Footnotes

Published ahead of print 17 December 2012

REFERENCES

  • 1. Fuchs PC, Barry AL, Brown SD. 2002. In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 49:467–470 [DOI] [PubMed] [Google Scholar]
  • 2. Kirkpatrick P, Raja A, LaBonte J, Lebbos J. 2003. Daptomycin. Nat. Rev. Drug Discov. 2:943–944 [DOI] [PubMed] [Google Scholar]
  • 3. Safdar N, Andes D, Craig WA. 2004. In vivo pharmacodynamic activity of daptomycin. Antimicrob. Agents Chemother. 48:63–68 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Petersen PJ, Bradford PA, Weiss WJ, Murphy TM, Sum PE, Projan SJ. 2002. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant Gram-positive pathogens. Antimicrob. Agents Chemother. 46:2595–2601 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT. 2003. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:1714–1718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Schriever CA, Fernandez C, Rodvold KA, Danziger LH. 2005. Daptomycin: a novel cyclic lipopeptide antimicrobial. Am. J. Health Syst. Pharm. 62:1145–1158 [DOI] [PubMed] [Google Scholar]
  • 7. Steenbergen JN, Alder J, Thorne GM, Tally FP. 2005. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 55:283–288 [DOI] [PubMed] [Google Scholar]
  • 8. Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer AS. 2009. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:2312–2318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Bertsche U, Weidenmaier C, Kuehner D, Yang SJ, Baur S, Francois P, Schrenzel J, Yeaman MR, Bayer AS. 2011. Correlation of daptomycin-resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation. Antimicrob. Agents Chemother. 55:3922–3928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Jones T, Yeaman MR, Sakoulas G, Yang SJ, Proctor RA, Sahl HG, Schrenzel J, Xiong YQ, Bayer AS. 2008. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob. Agents Chemother. 52:269–278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Koprivnjak T, Peschel A. 2011. Bacterial resistance mechanisms against host defense peptides. Cell. Mol. Life Sci. 68:2243–2254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Mishra NN, Rubio A, Nast CC, Bayer AS. 2012. Differential adaptations of methicillin-resistant S. aureus to serial in vitro passage in daptomycin resulting in evolution of daptomycin resistance: role of cell membrane carotenoid content and fluidity. Int. J. Microbiol. 2012:683450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Rubio A, Moore J, Varoglu M, Conrad M, Chu M, Shaw W, Silverman JA. 2012. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF. Mol. Mem. Biol. 29:1–8 [DOI] [PubMed] [Google Scholar]
  • 14. Xiong YQ, Mukhopadhyay K, Yeaman MR, Adler-Moore J, Bayer AS. 2005. Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3114–3121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Mishra NN, Liu G, Yeaman MR, Nast CC, Proctor RA, McKinnell J, Bayer AS. 2011. Carotenoid related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 55:526–531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Friedman L, Adler JD, Silverman JA. 2006. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:2137–2145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Ernst CM, Peschel A. 2011. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol. Microbiol. 80:290–299 [DOI] [PubMed] [Google Scholar]
  • 18. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 193:1067–1076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Yang SJ, Xiong YQ, Dunman PM, Schrenzel J, François P, Peschel A, Bayer AS. 2009. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrob. Agents Chemother. 53:2636–2637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Mishra NN, Rubio A, Bayer AS. 2012. Cell membrane lipid profiles correlate with daptomycin resistance in methicilin-resistant Staphylococcus aureus, abstr C1-1744. Abstr. 52nd Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC) American Society for Microbiology, Washington, DC [Google Scholar]
  • 21. Mishra NN, McKinnell J, Yeaman MR, Rubio A, Nast CC, Chen L, Kreiswirth BN, Bayer AS. 2011. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 55:4012–4018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. 2003. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl. Environ. Microbiol. 69:18–23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S, Kreiswirth BN. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:3556–3563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Chen L, Mediavilla JR, Oliveira DC, Willey BM, de Lencastre H, Kreiswirth BN. 2009. Multiplex real-time PCR for rapid Staphylococcal cassette chromosome mec typing. J. Clin. Microbiol. 47:3692–3706 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS. 2010. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob. Agents Chemother. 54:3079–3085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Li M, Rigby K, Lai Y, Nair V, Peschel A, Schittek B, Otto M. 2009. Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob. Agents Chemother. 53:4200–4210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Mishra NN, Bayer AS, Tran TT, Shamoo Y, Mileykovskaya E, Dowhan W, Guan Z, Arias CA. 2012. Daptomycin resistance in enterococci is associated with distinct alteration of cell membrane phospholipid content. PLoS One 7(8):e43958 doi:10.1371/journal.pone.0043958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Mukhopadhyay K, Whitmire W, Xiong YQ, Molden J, Peschel A, McNamara PJ, Proctor RA, Yeaman MR, Bayer AS. 2007. Reduced in vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 is associated with alterations in cell membrane phospholipid composition and asymmetry. Microbiology 153:1187–1197 [DOI] [PubMed] [Google Scholar]
  • 29. Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, Xiong YQ, Cheung AL. 2012. The role of the Staphylococcus aureus GraRS two-component regulatory system in sensing of and resistance to cationic antimicrobial peptides. Infect. Immun. 80:74–81 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. 2009. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 5(11):e1000660 doi:10.1371/journal.ppat.1000660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Kilelee E, Pokorny A, Yeaman MR, Bayer AS. 2010. Lysyl- phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance. Antimicrob. Agents Chemother. 54:4476–4479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Hachmann AB, Sevim E, Gaballa A, Popham DL, Antelmann H, Helmann JD. 2011. Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis. Antimicrob. Agents Chemother. 55:4326–4337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Muraih JK, Harris J, Taylor SD, Palmer M. 2012. Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation. Biochim. Biophys. Acta 1818:673–678 [DOI] [PubMed] [Google Scholar]
  • 34. Bayer AS, Kupferwasser LI, Brown MH, Skurray RA, Grkovic S, Jones T, Mukhopadhay K, Yeaman MR. 2000. In vitro resistance of Staphylococcus aureus to thrombin-induced microbicidal protein is associated with alterations in membrane fluidity. Infect. Immun. 68:3548–3553 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES